Barton A. Kamen

6.4k total citations · 2 hit papers
99 papers, 5.1k citations indexed

About

Barton A. Kamen is a scholar working on Public Health, Environmental and Occupational Health, Rheumatology and Molecular Biology. According to data from OpenAlex, Barton A. Kamen has authored 99 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Public Health, Environmental and Occupational Health, 29 papers in Rheumatology and 28 papers in Molecular Biology. Recurrent topics in Barton A. Kamen's work include Acute Lymphoblastic Leukemia research (45 papers), Folate and B Vitamins Research (27 papers) and Childhood Cancer Survivors' Quality of Life (17 papers). Barton A. Kamen is often cited by papers focused on Acute Lymphoblastic Leukemia research (45 papers), Folate and B Vitamins Research (27 papers) and Childhood Cancer Survivors' Quality of Life (17 papers). Barton A. Kamen collaborates with scholars based in United States, Canada and Greece. Barton A. Kamen's co-authors include Robert S. Kerbel, Richard G.W. Anderson, Stephen W. Lacey, Karen G. Rothberg, Peter D. Cole, Leslie R. Coney, Vincent R. Zurawski, Steven Weitman, Angela K. Smith and J. Douglas Caston and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Barton A. Kamen

98 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anti-angiogenic basis of metronomic chemotherapy

2004 1.1k citations Robert S. Kerbel, Barton A. Kamen Nature reviews. Cancer profile →
Potocytosis: Sequestration and Transport of Small Molecules by Caveolae

1992 646 citations Barton A. Kamen et al. profile →

Peers

Countries citing papers authored by Barton A. Kamen

Since Specialization

Citations

This map shows the geographic impact of Barton A. Kamen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barton A. Kamen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barton A. Kamen more than expected).

Fields of papers citing papers by Barton A. Kamen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barton A. Kamen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barton A. Kamen. The network helps show where Barton A. Kamen may publish in the future.

Co-authorship network of co-authors of Barton A. Kamen

This figure shows the co-authorship network connecting the top 25 collaborators of Barton A. Kamen. A scholar is included among the top collaborators of Barton A. Kamen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barton A. Kamen. Barton A. Kamen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can Targeted Therapy be Successful without Metronomic Scheduling ? 2012 ·Current Topics in Medicinal Chemistry ·Nicolás André, Eddy Pasquier, Barton A. Kamen	4
2	Folate Homeostasis in Cerebrospinal Fluid During Therapy for Acute Lymphoblastic Leukemia 2008 ·Pediatric Neurology ·Peter D. Cole, (unknown), Veena Vijayanathan, Sudipta Roychowdhury, Angela K. Smith, Barton A. Kamen	40
3	Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer 2008 ·The Journal of Nutritional Biochemistry ·Robert S. Chapkin, Barton A. Kamen, Evelyn Callaway, Laurie A. Davidson, Nysia I. George, Naisyin Wang, Joanne R. Lupton, Richard H. Finnell	20
4	High-performance liquid chromatography separation of aminopterin-polyglutamates within red blood cells of children treated for acute lymphoblastic leukemia 2007 ·Translational research ·Veena Vijayanathan, Angela K. Smith, John A. Zebala, Barton A. Kamen, Peter D. Cole	2
5	5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside (AICA-riboside) as a Targeting Agent for Therapy of Patients With Acute Lymphoblastic Leukemia: Are We There and Are There Pitfalls? 2007 ·Journal of Pediatric Hematology/Oncology ·Bruce N. Cronstein, Barton A. Kamen	7
6	Metronomic Therapy From a Pharmacologist??s View 2006 ·Journal of Pediatric Hematology/Oncology ·Barton A. Kamen, John Glod, Peter D. Cole	13
7	High‐Dose Methotrexate in Acute Lymphoblastic Leukemia: Where Is the Evidence for Its Continued Use? 2005 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Elpis Mantadakis, Peter D. Cole, Barton A. Kamen	46
8	The anti-angiogenic basis of metronomic chemotherapy breakdown → 2004 ·Nature reviews. Cancer ·Robert S. Kerbel, Barton A. Kamen	1105
9	Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs 2002 ·Cancer Chemotherapy and Pharmacology ·Peter D. Cole, Angela K. Smith, Barton A. Kamen	21
10	DEXTROMETHORPHAN IS EFFECTIVE IN THE TREATMENT OF SUBACUTE METHOTREXATE NEUROTOXICITY 2002 ·Pediatric Hematology and Oncology ·Richard A. Drachtman, Peter D. Cole, Carla Golden, S. Jill James, Stepan Melnyk, Joseph Aisner, Barton A. Kamen	103
11	Ratio of Methotrexate to Folate Uptake by Lymphoblasts in Children With B-Lineage Acute Lymphoblastic Leukemia: A Pilot Study 2000 ·The American journal of pediatric hematology/oncology ·Elpis Mantadakis, Angela K. Smith, Barton A. Kamen	11
12	PARAMENINGEAL ALVEOLAR RHABDOMYOSARCOMA WITH AN ISOLATED PANCREATIC METASTASIS 1999 ·Pediatric Hematology and Oncology ·Roula Farah, Barton A. Kamen	9
13	PMA alters folate receptor distribution in the plasma membrane and increases the rate of 5-methyltetrahydrofolate delivery in mature MA104 cells 1998 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Angela K. Smith, Charles Nguyen, Barton A. Kamen	10
14	Evidence for Negative Feedback of Extracellular Methotrexate on Blasts of Acute Lymphoblastic Leukemia in Vitro 1997 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Angela K. Smith, Richard H. Lark, Naomi Winick, Barton A. Kamen	6
15	Accumulation of Methotrexate in Systemic Tissues after Intrathecal Administration 1997 ·Journal of Pediatric Hematology/Oncology ·W. Archie Bleyer, J. Arly Nelson, Barton A. Kamen	25
16	Identification of two mutant alleles of transcobalamin II in an affected family 1994 ·Human Molecular Genetics ·Ning Li, David S. Rosenblatt, Barton A. Kamen, Shakuntla Seetharam, Bellur Seetharam	28
17	Accumulation of 5‐methyltetrahydrofolic acid and folylpolyglutamate synthetase expression by mitogen stimulated human lymphocytes 1993 ·British Journal of Haematology ·Daniel W. Fort, Richard H. Lark, Angela K. Smith, M Marling-Cason, Steven Weitman, Barry Shane, Barton A. Kamen	15
18	Phase II trial of ICRF-187 in children with solid tumors and acute leukemia 1991 ·Investigational New Drugs ·Tribhawan S. Vats, Barton A. Kamen, Jeffrey P. Krischer	13
19	Folate and Methotrexate Polyglutamate Tissue Levels in Rhesus Monkeys Following Chronic Low-Dose Methotrexate 1987 ·PubMed ·Naomi Winick, Barton A. Kamen, Frank M. Balis, John S. Holcenberg, (unknown), David G. Poplack	16
20	Exchange transfusion as a treatment for hyperleukocytosis, anemia, and metabolic abnormalities in a patient with leukemia 1980 ·The Journal of Pediatrics ·Barton A. Kamen, (unknown), Howard A. Pearson	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact